Clls stock after hours

CLLS Stock Price Quote & News - Cellectis | Robinhood You can watch CLLS and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cellectis against related stocks people have also bought. Cellectis S.A. ADR Research & Ratings (CLLS) | Barron's

Cellectis SA (NASDAQ:CLLS) has been assigned an average rating of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the […] Cellectis S.A. (CLLS) Stock Forum & Discussion - Yahoo Finance Find the latest Cellectis S.A. (CLLS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. CLLS - Benzinga Jan 01, 2010 · Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer Cellectis S.A (CLLS) Stock Message Board - InvestorsHub Oct 01, 2019 · Add CLLS Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+

CLLS - Cellectis SA Stock quote - CNNMoney.com

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither TradingDay.com nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. CLLS | Cellectis S.A. ADR Stock Price & News - WSJ Cellectis S.A. ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time CLLS stock price. Dow Jones, a News Corp company. AFTER HOURS Vol 13; Volume 123,515. Cellectis S.A. (CLLS) Latest Stock News & Headlines ... Get the latest Cellectis S.A. (CLLS) stock news and headlines to help you in your trading and investing decisions.

Nov 14, 2018 · clls stock to take or not to take? Stock like roulette – today green, tomorrow red. You can seriously increase your capital after a while or, conversely, after a while your capital may decline. Terms of investing in clls stock. When investing in a tool like stocks, you need to focus on a long term: a few years or a few dozen years.

News stories about CLLS stock have been trending neutral on Wednesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. CLLS | Cellectis S.A. ADR Analyst Estimates & Rating – WSJ Cellectis S.A. ADR analyst ratings, historical stock prices, earnings estimates & actuals. CLLS updated stock price target summary. Dow Jones, a News Corp company AFTER HOURS Vol 4; Volume Cellectis SA : CLLS Stock Price Quote at Ally Invest Free current stock price quotes and data for Cellectis SA (CLLS). Research news, charts, stock market performance and earnings. MT Newswires After-Hours News Movers Cellectis S.A (CLLS) firmed 1% after the company said the US Patent and Trademark Office granted a patent to the company for methods of preparing European ADRs Move Lower

Cellectis S.A. (CLLS) Stock Analysis & News | Seeking Alpha

CLLS stock quote, chart and news. Get Cellectis SA's stock price today. CLLS - TradingDay.com - After Hours Trading

After-Hours Stock Movers 04/03: (EDAP) (HCC) (AEHR) Higher ...

60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Clls stock - Stock Nov 14, 2018 · clls stock to take or not to take? Stock like roulette – today green, tomorrow red. You can seriously increase your capital after a while or, conversely, after a while your capital may decline. Terms of investing in clls stock. When investing in a tool like stocks, you need to focus on a long term: a few years or a few dozen years.

CLLS Stock Summary. With a year-over-year growth in debt of 2,216.27%, Cellectis SA's debt growth rate surpasses 98.43% of about US stocks. In terms of twelve month growth in earnings before interest and taxes, Cellectis SA is reporting a growth rate of 404.86%; that's higher than 96.71% of US stocks. Cellectis SA (NASDAQ:CLLS) Sees Significant Drop in Short ...